Ondansetron for the Treatment of Methamphetamine Dependence - 1

NCT00040053 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

154

Enrollment

NIH

Sponsor class

Conditions

Amphetamine-Related Disorders

Interventions

DRUG: Ondansetron

Sponsor

National Institute on Drug Abuse (NIDA)

Collaborators

[object Object]